Business Description
MARX Biotech Co Ltd
ISIN : TW0007731002
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.65 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 24.16 | |||||
Beneish M-Score | 0.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.29 | |||||
9-Day RSI | 25.13 | |||||
14-Day RSI | 27.67 | |||||
6-1 Month Momentum % | 9.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.13 | |||||
Quick Ratio | 1.57 | |||||
Cash Ratio | 0.59 | |||||
Days Inventory | 191.42 | |||||
Days Sales Outstanding | 73.05 | |||||
Days Payable | 50.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.5 | |||||
Shareholder Yield % | -3.84 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.78 | |||||
Operating Margin % | -12.82 | |||||
Net Margin % | -15.02 | |||||
FCF Margin % | -16.59 | |||||
ROE % | -29.03 | |||||
ROA % | -19.87 | |||||
ROIC % | -34.87 | |||||
ROC (Joel Greenblatt) % | -90.95 | |||||
ROCE % | -29.65 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.38 | |||||
PB Ratio | 15.51 | |||||
Price-to-Tangible-Book | 18.24 | |||||
EV-to-EBIT | -54.32 | |||||
EV-to-EBITDA | -62.85 | |||||
EV-to-Revenue | 8.39 | |||||
EV-to-FCF | -51.51 | |||||
Price-to-Net-Current-Asset-Value | 20.7 | |||||
Earnings Yield (Greenblatt) % | -1.84 | |||||
FCF Yield % | -1.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MARX Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 444.162 | ||
EPS (TTM) (NT$) | -0.085 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 27.67 | ||
14-Day ATR (NT$) | 0.429461 | ||
20-Day SMA (NT$) | 8.2945 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (NT$) | 3.9 - 15.5 | ||
Shares Outstanding (Mil) | 498.06 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MARX Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MARX Biotech Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
MARX Biotech Co Ltd Frequently Asked Questions
What is MARX Biotech Co Ltd(ROCO:7731)'s stock price today?
When is next earnings date of MARX Biotech Co Ltd(ROCO:7731)?
Does MARX Biotech Co Ltd(ROCO:7731) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |